3.14 USD
▲-0.07+9.60%
盘后 2.78 -2.97%
2026-08-03
市值
$1.98M
市盈率
—
EPS
-1787.37
股息率
—
52 周区间
2.53 – 3,800.00
成交量
73.38K
Beta
1.46
目标价
—
52W 低 2.5352W 高 3,800.00
价格走势
公司简介
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also ...